MedPath

PROTAMINE SULFATE INJECTION USP

PROTAMINE SULFATE INJECTION USP

Approved
DIN Number

02231674

Drug Class

Human

Market Date

Mar 3, 1998

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02231674
AIG Number0107652001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V03AB14 PROTAMINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification20:28.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

PROTAMINE SULFATEActive
Strength: 10 MG / ML
Monograph: PROTAMINE SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.